Simulations Plus Basic EPS 2010-2024 | SLP
Simulations Plus basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Simulations Plus Annual Basic EPS |
| 2024 |
$0.50 |
| 2023 |
$0.50 |
| 2022 |
$0.62 |
| 2021 |
$0.49 |
| 2020 |
$0.52 |
| 2019 |
$0.49 |
| 2018 |
$0.52 |
| 2017 |
$0.34 |
| 2016 |
$0.29 |
| 2015 |
$0.23 |
| 2014 |
$0.19 |
| 2013 |
$0.18 |
| 2012 |
$0.19 |
| 2011 |
$0.17 |
| 2010 |
$0.14 |
| 2009 |
$0.09 |
| Simulations Plus Quarterly Basic EPS |
| 2024-08-31 |
$0.04 |
| 2024-05-31 |
$0.16 |
| 2024-02-29 |
$0.20 |
| 2023-11-30 |
$0.10 |
| 2023-08-31 |
$0.03 |
| 2023-05-31 |
$0.20 |
| 2023-02-28 |
$0.21 |
| 2022-11-30 |
$0.06 |
| 2022-08-31 |
$0.05 |
| 2022-05-31 |
$0.20 |
| 2022-02-28 |
$0.22 |
| 2021-11-30 |
$0.15 |
| 2021-08-31 |
$0.02 |
| 2021-05-31 |
$0.19 |
| 2021-02-28 |
$0.16 |
| 2020-11-30 |
$0.12 |
| 2020-08-31 |
$0.11 |
| 2020-05-31 |
$0.17 |
| 2020-02-29 |
$0.12 |
| 2019-11-30 |
$0.12 |
| 2019-08-31 |
$0.12 |
| 2019-05-31 |
$0.16 |
| 2019-02-28 |
$0.12 |
| 2018-11-30 |
$0.09 |
| 2018-08-31 |
$0.08 |
| 2018-05-31 |
$0.14 |
| 2018-02-28 |
$0.20 |
| 2017-11-30 |
$0.10 |
| 2017-08-31 |
$0.07 |
| 2017-05-31 |
$0.12 |
| 2017-02-28 |
$0.07 |
| 2016-11-30 |
$0.08 |
| 2016-08-31 |
$0.04 |
| 2016-05-31 |
$0.11 |
| 2016-02-29 |
$0.07 |
| 2015-11-30 |
$0.07 |
| 2015-08-31 |
$0.03 |
| 2015-05-31 |
$0.11 |
| 2015-02-28 |
$0.06 |
| 2014-11-30 |
$0.03 |
| 2014-08-31 |
$0.02 |
| 2014-05-31 |
$0.08 |
| 2014-02-28 |
$0.05 |
| 2013-11-30 |
$0.04 |
| 2013-08-31 |
$0.01 |
| 2013-05-31 |
$0.06 |
| 2013-02-28 |
$0.07 |
| 2012-11-30 |
$0.04 |
| 2012-08-31 |
$0.03 |
| 2012-05-31 |
$0.05 |
| 2012-02-29 |
$0.05 |
| 2011-11-30 |
$0.06 |
| 2011-08-31 |
$0.01 |
| 2011-05-31 |
$0.07 |
| 2011-02-28 |
$0.06 |
| 2010-11-30 |
$0.04 |
| 2010-08-31 |
$0.02 |
| 2010-05-31 |
$0.05 |
| 2010-02-28 |
$0.04 |
| 2009-11-30 |
$0.03 |
| 2009-08-31 |
$0.01 |
| 2009-05-31 |
$0.04 |
| 2009-02-28 |
$0.02 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.557B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
